Matches in SemOpenAlex for { <https://semopenalex.org/work/W2979771750> ?p ?o ?g. }
- W2979771750 endingPage "231" @default.
- W2979771750 startingPage "217" @default.
- W2979771750 abstract "Treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute leukemia (Ph+ ALL) has been revolutionized with the advent of tyrosine kinase inhibitors (TKIs). Most patients with CML achieve long-term survival similar to individuals without CML due to treatment with TKIs not only in frontline but also in further lines of therapy. The third-generation TKI ponatinib has demonstrated efficacy in patients with refractory CML and Ph+ ALL. Ponatinib is currently the most potent TKI in this setting demonstrating activity against T315I mutant clones. However, ponatinib’s safety data revealed a dose-dependent, increased risk of serious cardiovascular (CV) events. Guidance is needed to evaluate the benefit–risk profile of TKIs, such as ponatinib, and safety measures to prevent treatment-associated CV events. An expert panel of German hematologists and cardiologists summarize current evidence regarding ponatinib’s efficacy and CV safety profile. We propose CV management strategies for patients who are candidates for ponatinib." @default.
- W2979771750 created "2019-10-18" @default.
- W2979771750 creator A5005641797 @default.
- W2979771750 creator A5009383961 @default.
- W2979771750 creator A5013024565 @default.
- W2979771750 creator A5023015071 @default.
- W2979771750 creator A5031143092 @default.
- W2979771750 creator A5035072666 @default.
- W2979771750 creator A5038582279 @default.
- W2979771750 creator A5046917965 @default.
- W2979771750 creator A5057432758 @default.
- W2979771750 creator A5059485343 @default.
- W2979771750 creator A5067656237 @default.
- W2979771750 creator A5070260720 @default.
- W2979771750 creator A5078221812 @default.
- W2979771750 creator A5080895047 @default.
- W2979771750 creator A5087351196 @default.
- W2979771750 creator A5087916167 @default.
- W2979771750 date "2019-10-07" @default.
- W2979771750 modified "2023-10-18" @default.
- W2979771750 title "Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management" @default.
- W2979771750 cites W1523946531 @default.
- W2979771750 cites W1965429870 @default.
- W2979771750 cites W1969672788 @default.
- W2979771750 cites W2029573515 @default.
- W2979771750 cites W2035278640 @default.
- W2979771750 cites W2048262171 @default.
- W2979771750 cites W2095846263 @default.
- W2979771750 cites W2096045098 @default.
- W2979771750 cites W2115626434 @default.
- W2979771750 cites W2140351909 @default.
- W2979771750 cites W2141106022 @default.
- W2979771750 cites W2147109509 @default.
- W2979771750 cites W2165537263 @default.
- W2979771750 cites W2166807441 @default.
- W2979771750 cites W2179788614 @default.
- W2979771750 cites W2258178934 @default.
- W2979771750 cites W2261433444 @default.
- W2979771750 cites W2339658711 @default.
- W2979771750 cites W2339943063 @default.
- W2979771750 cites W2344488712 @default.
- W2979771750 cites W2402599050 @default.
- W2979771750 cites W2483008971 @default.
- W2979771750 cites W2495072828 @default.
- W2979771750 cites W2526416288 @default.
- W2979771750 cites W2599899418 @default.
- W2979771750 cites W2604410663 @default.
- W2979771750 cites W2740029254 @default.
- W2979771750 cites W2745344769 @default.
- W2979771750 cites W2766720469 @default.
- W2979771750 cites W2785001175 @default.
- W2979771750 cites W2788740799 @default.
- W2979771750 cites W2790692615 @default.
- W2979771750 cites W2802600340 @default.
- W2979771750 cites W2888589263 @default.
- W2979771750 cites W2890670704 @default.
- W2979771750 cites W2891471485 @default.
- W2979771750 cites W2891752553 @default.
- W2979771750 cites W2902317207 @default.
- W2979771750 cites W2908998660 @default.
- W2979771750 cites W2931981435 @default.
- W2979771750 cites W2946505601 @default.
- W2979771750 cites W3021842026 @default.
- W2979771750 cites W2805087835 @default.
- W2979771750 doi "https://doi.org/10.1159/000501927" @default.
- W2979771750 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7384349" @default.
- W2979771750 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31590170" @default.
- W2979771750 hasPublicationYear "2019" @default.
- W2979771750 type Work @default.
- W2979771750 sameAs 2979771750 @default.
- W2979771750 citedByCount "21" @default.
- W2979771750 countsByYear W29797717502020 @default.
- W2979771750 countsByYear W29797717502021 @default.
- W2979771750 countsByYear W29797717502022 @default.
- W2979771750 countsByYear W29797717502023 @default.
- W2979771750 crossrefType "journal-article" @default.
- W2979771750 hasAuthorship W2979771750A5005641797 @default.
- W2979771750 hasAuthorship W2979771750A5009383961 @default.
- W2979771750 hasAuthorship W2979771750A5013024565 @default.
- W2979771750 hasAuthorship W2979771750A5023015071 @default.
- W2979771750 hasAuthorship W2979771750A5031143092 @default.
- W2979771750 hasAuthorship W2979771750A5035072666 @default.
- W2979771750 hasAuthorship W2979771750A5038582279 @default.
- W2979771750 hasAuthorship W2979771750A5046917965 @default.
- W2979771750 hasAuthorship W2979771750A5057432758 @default.
- W2979771750 hasAuthorship W2979771750A5059485343 @default.
- W2979771750 hasAuthorship W2979771750A5067656237 @default.
- W2979771750 hasAuthorship W2979771750A5070260720 @default.
- W2979771750 hasAuthorship W2979771750A5078221812 @default.
- W2979771750 hasAuthorship W2979771750A5080895047 @default.
- W2979771750 hasAuthorship W2979771750A5087351196 @default.
- W2979771750 hasAuthorship W2979771750A5087916167 @default.
- W2979771750 hasBestOaLocation W29797717501 @default.
- W2979771750 hasConcept C104317684 @default.
- W2979771750 hasConcept C121608353 @default.
- W2979771750 hasConcept C126322002 @default.
- W2979771750 hasConcept C138626823 @default.
- W2979771750 hasConcept C143998085 @default.